Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment

References

• Gazzaruso C. Erectile Dysfunction and silent myocardial ischemia. In: Harrison's Principles of Internal Medicine, 16th Edition Online. DL Kasper (Ed.). McGraw Hill, OH, USA (2005).
   Google Scholar
• Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 84, 50–56 (1999).
   PubMed Web of Science ®Google Scholar
• Feldman HA, Goldstein I, Hatzchristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results from the Massachusetts male aging study. J. Urol. 151, 54–61 (1994).
   PubMed Web of Science ®Google Scholar
• Romeo JH, Seftel AD, Madhun ZT, Aron DC. Sexual function in men with diabetes type 2: association with glycemic control. J. Urol. 163, 788–791 (2000).
   PubMed Web of Science ®Google Scholar
• Fedele D, Bortolotti A, Coscelli C et al; Gruppo Italiano Studio Deficit Erettile nei Diabetici. Erectile dysfuncion in Type 1 and Type 2 diabetics in Italy. Int. J. Epidemiol. 29, 524–531 (2000).
   PubMed Web of Science ®Google Scholar
• Montorsi P, Montorsi F, Schulman CC. Is erectile dysfunction the ‘tip of the iceberg’ of a systemic vascular dysorder? Eur. Urol. 44, 352–354 (2003).
   PubMed Web of Science ®Google Scholar
• Cheitlin MD. Should the patient with coronary artery disease use sildenafil? Prev. Cardiol. 6, 161–165 (2003).
   PubMedGoogle Scholar
• Montorsi F. Briganti A, Salonia A et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur. Urol. 44, 360–364 (2003).
   PubMed Web of Science ®Google Scholar
• Blumentals WA, Gomez-Caminero A, Joo S, Vannappagari V. Should erectile dysfunction be considered as a marker for acute myocardial inferction? Results from a retrospective cohort study. Int. J. Impot. Res. 16, 350–353 (2004).
   PubMed Web of Science ®Google Scholar
• Kawanishi Y, Lee KS, Kimura K et al. Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunctional patients. Int. J. Impot. Res. 13, 100–103 (2001).
   PubMed Web of Science ®Google Scholar
• Kloner RA, Mullin SH, Shook T et al. Erectile dysfunction in the cardiac patient: how common and should we treat? J. Urol. 170, S46–S50 (2003).
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Rokkas K, Ioakeimidis N et al. Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study. Eur. Urol. (Epub.) (2005).
   PubMedGoogle Scholar
• Chiurlia E, D’Amico R, Ratti C, Granata AR, Romagnoli R, Modena MG. Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J. Am. Coll. Cardiol. 46, 1503–1506 (2005).
   PubMed Web of Science ®Google Scholar
• Ponholzer A, Temml C, Obermayr R, Wehrberger C, Madersbacher S. Is erectile dysfunction an indicator for increased risk for coronary heart disease and stroke. Eur. Urol. 48, 512–518 (2005)
   PubMed Web of Science ®Google Scholar
• Greenstein A, Chen J, Miller H, Matzkin H, Villa Y, Braf Z. Does severity of ischemic coronary disease correlate with erectile function? Int. J. Impot. Res. 9, 123–126 (1997).
   PubMed Web of Science ®Google Scholar
• Solomon H, Man JW, Wierzbicki AS, Jackson G. Relation of erectile dysfunction to angiographic coronary artery disease. Am. J. Cardiol. 91, 230–231 (2003).
   PubMed Web of Science ®Google Scholar
• Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA 294, 2996–3002 (2005)
   PubMed Web of Science ®Google Scholar
• Gazzaruso C, Pujia A, Solerte SB et al. Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients. Int. J. Impot. Res. published online on Oct 13 (2005)
   Google Scholar
• Gazzaruso C, Giordanetti S, De Amici E et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 110, 22–26 (2004).
   PubMed Web of Science ®Google Scholar
• Stern S. Symptoms other than chest pain may be important in the diagnosis of ‘silent ischemia’, or ‘the sounds of silence’. Circulation 111, e435–e437 (2005).
   Google Scholar
• Ashley EA, Raxval V, Finlay M, Froelicher V. Diagnosing coronary artery disease in diabetic patients. Diabetes Metab. Res. Rev. 18, 201–208 (2002).
   PubMed Web of Science ®Google Scholar
• Solomon H, DeBusk RF. Contemporary management of silent ischemia: the role of ambulatory monitoring. Int. J. Cardiol. 96, 311–319 (2004).
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 21, 1551–1559 (1998).
   PubMedGoogle Scholar
• Grundy SM, Cleeman JI, Merz CNB et al; National Cholesterol Education Program. Implications of the recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110, 227–239 (2004).
   PubMed Web of Science ®Google Scholar
• Kirby M, Jackson G, Simonsen U. Endothelial dysfunction linkes erectile dysfunction to heart disease. Int. J. Clin. Pract. 59, 225–229 (2005).
   PubMed Web of Science ®Google Scholar
• Gazzaruso C. Current opinion on the relationships between athero-thrombosis, type 2 diabetes mellitus and erectile dysfunction. Recenti. Progr. Med. 96, 155–158 (2005).
   PubMedGoogle Scholar
• Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 26, 1553–1579 (2003).
   PubMed Web of Science ®Google Scholar
• Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J. Am. Coll. Cardiol. 43, 179–184 (2004).
   PubMed Web of Science ®Google Scholar
• Yavuzgil O, Altay B, Zoghi M, Gurgun C, Kayikcioglu M, Kultursay H. Endothelial function in patients with vasculogenic erectile dysfunction. Int. J. Cardiol. 103, 19–26 (2005).
   PubMed Web of Science ®Google Scholar
• Bivalacqua TB, Champion HC, Usta MF et al. RhoA/Rho-kinase suppresses endothelium nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction. Proc. Natl Acad. USA 101, 9121–9126 (2004).
   PubMed Web of Science ®Google Scholar
• Sullivan ME, Dashwood MR, Thompson CS, Muddle JR, Mikhailidis DP, Morgan RJ. Alterations in endothelin B receptor sites in cavernosal tissue of diabetic rabbits: potential relevance to the pathogenesis of erectile dysfunction. J. Urol. 158, 1966–1972 (1997).
   PubMed Web of Science ®Google Scholar
• Francavilla S, Properzi G, Bellini C, Marino G, Ferri C, Santucci A. Endothelin-1 in diabetic and nondiabetic men with erectile dysfunction. J. Urol. 158, 1770–1774 (1997).
   PubMed Web of Science ®Google Scholar
• Endemann DH, Schiffrin EL. Endothelial dysfunction. J. Am. Soc. Nephrol. 15, 1983–1992 (2004).
   PubMed Web of Science ®Google Scholar
• Gnduz MI, Gumus BH, Sekuri C. Relationship between metabolic sindrome and erectile dysfunction. Asian J. Androl. 6, 355–358 (2004).
   PubMed Web of Science ®Google Scholar
• Esposito K, Giugliano F, Martedì E et al. High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care 28, 1201–1203 (2005).
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 112(17), 2735–2752 (2005).
   PubMed Web of Science ®Google Scholar
• Fonseca V, Seftel A, Denne J, Fredlund P. Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia 47, 1914–1923 (2004).
   PubMed Web of Science ®Google Scholar
• Metro MJ, Broderick GA. Diabetes and vascular impotence: does insulin dependence increase the relative severity? Int. J. Impot. Res. 11, 87–89 (1999).
   PubMed Web of Science ®Google Scholar
• Gazzaruso C, Giordanetti S, De Amici E et al. Reply of the authors. Circulation 111, e18–e19 (2005).
   Google Scholar
• Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int. J. Impot. Res. 11, 319–326 (1999).
   PubMed Web of Science ®Google Scholar
• Kostis JB, Jackson G, Rosen R et al. Sexual dysfunction and cardiac risk (the second Princeton consensus conference). Am. J. Cardiol. 96, 313–321 (2005).
   PubMed Web of Science ®Google Scholar
• Arruda-Olson AM, Pellikka P. Appropriate use of exercise-testing prior to administration of drugs for treatment of erectile dysfunction. Herz 28, 291–297 (2003).
   PubMed Web of Science ®Google Scholar
• Expert Panel of detection,evaluation, and treatment of high blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001).
   PubMed Web of Science ®Google Scholar
• Cheitlin MD, Hutter A M, Brindis RG, et al. Use of sildenafil (Viagra) in patients with cardiovascular disease. Circulation 99, 168–177 (1999).
   PubMed Web of Science ®Google Scholar
• Hermann HC, Chang G, Klugherz BD, Mahoney PD. Hemodynamic effects of sildenafil in men with severe coronary artery disease. New Engl. J. Med. 342, 1622–1626 (2000).
   Google Scholar
• Halcox JPJ, Nour KRA, Zalos G et al. The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. J. Am. Coll. Cardiol. 40, 1232–1240 (2002).
   PubMed Web of Science ®Google Scholar
• DeBusk RF, Pepine CJ, Glasser DB et al. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease. Am. J. Cardiol. 93, 147–153 (2004).
   PubMed Web of Science ®Google Scholar
• Fox KM, Thadani U, Ma PT et al. Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. Eur. Heart J. 24, 2206–2212 (2003)
   Google Scholar
• Arruda-Olson AM, Mahoney DW, Nehra A et al. Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial. JAMA 287, 719–725 (2002).
   PubMed Web of Science ®Google Scholar
• Thadani U, Smith W, Nash S et al. The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. J. Am. Coll. Cardiol. 40, 2006–2012 (2002)
   PubMed Web of Science ®Google Scholar
• Kloner RA, Mitchell M, Emmick JT. Cardiovascular effects of tadalafil. Am. J. Cardiol. 92(Suppl.), 37M-46M (2003).
   PubMed Web of Science ®Google Scholar
• Desouza C, Parulkar A, Lumpkin D, Akers D, Fonseca VA. Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilation in type 2 diabetes. Diabetes Care 25, 1336–1339 (2002).
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Hirata K, O’Rourke MF. Effect of sildenafil on arterial stiffness and wave reflection. Vasc. Med. 8, 243–248 (2003).
   PubMed Web of Science ®Google Scholar
• Fink HA, MacDonald R, Rutks IR, Nelson DB, Wilt TJ. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch. Intern. Med. 162, 1349–1360 (2002).
   Google Scholar
• Vinik AI, Richardson D. Erectile dysfunction in diabetes. Diabetes Rev. 6, 16–33 (1998).
   Google Scholar
• Tan RS, Pu SJ. Impact of obesity on hypogonadism in the andropause. Int. J. Urol. 25, 195–201 (2002).
   Google Scholar
• Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 56, 302–306 (2000).
   PubMed Web of Science ®Google Scholar
• Esposito K, Giugliano F, Di Palo C et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled study. JAMA 291, 2978–2984 (2004).
   PubMed Web of Science ®Google Scholar
• Ferrario CM, Levy P. Sexual dysfunction in patients with hypertension: implications for Therapy. J. Clin. Hypertens. 4, 424–432 (2002).
   PubMedGoogle Scholar
• Dusing R. Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Pressure (Suppl. 2) 29–34 (2003).
   PubMedGoogle Scholar
• Toblli J, Stella I, Nestor Mazza O, Ferder L, Inserra F. Protection of cavernous tissue in male spontaneously hypertensive rats. Beyond blood pressure control. Am. J. Hypertens. 17, 516–522 (2004).
   PubMed Web of Science ®Google Scholar
• Park K, Shin JW, Oh JK, Ryu KS, Kim SW, Paick JS. Restoration of erectile dysfunction capacity in normatensive aged rats by modulation of angiotensin receptor type 1. J. Androl. 26, 123–128 (2005).
   PubMedGoogle Scholar